See more : GBX International Group Inc. (GBXI) Income Statement Analysis – Financial Results
Complete financial analysis of Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Beijing Chunlizhengda Medical Instruments Co., Ltd., a leading company in the Medical – Devices industry within the Healthcare sector.
- Belships ASA (NS6.BE) Income Statement Analysis – Financial Results
- SW Umwelttechnik Stoiser & Wolschner AG (SWUT.VI) Income Statement Analysis – Financial Results
- Inaba Denki Sangyo Co.,Ltd. (9934.T) Income Statement Analysis – Financial Results
- Arbe Robotics Ltd. (ARBE) Income Statement Analysis – Financial Results
- Net Lease Office Properties (NLOP) Income Statement Analysis – Financial Results
Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858.HK)
About Beijing Chunlizhengda Medical Instruments Co., Ltd.
Beijing Chunlizhengda Medical Instruments Co., Ltd., an orthopedic medical device company, engages in the research and development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China. It offers implantable orthopedic medical devices, which consist of joint prosthesis products and spinal products. The company primarily sells its products through distributors, or on ODM and OEM bases under the Chunli brand, as well as to hospitals directly. It also exports its products to various countries. The company was incorporated in 1998 and is headquartered in Beijing, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.21B | 1.20B | 1.11B | 937.69M | 855.33M | 497.93M | 300.32M | 207.93M | 177.37M | 134.53M | 110.55M | 98.09M |
| Cost of Revenue | 332.64M | 288.08M | 253.60M | 256.93M | 261.87M | 180.00M | 84.06M | 48.26M | 55.28M | 34.96M | 30.47M | 27.54M |
| Gross Profit | 875.89M | 913.53M | 854.54M | 680.76M | 593.46M | 317.92M | 216.25M | 159.66M | 122.09M | 99.58M | 80.07M | 70.56M |
| Gross Profit Ratio | 72.48% | 76.03% | 77.11% | 72.60% | 69.38% | 63.85% | 72.01% | 76.79% | 68.83% | 74.02% | 72.44% | 71.93% |
| Research & Development | 157.45M | 162.34M | 104.84M | 72.60M | 57.75M | 35.45M | 21.22M | 14.28M | 13.32M | 8.00M | 4.81M | 4.87M |
| General & Administrative | 9.70M | 10.95M | 10.68M | 14.20M | 7.38M | 6.21M | 6.89M | 6.09M | 24.34M | 18.55M | 13.58M | 14.86M |
| Selling & Marketing | 269.47M | 288.89M | 342.05M | 241.01M | 225.79M | 143.91M | 88.95M | 52.23M | 23.62M | 12.93M | 8.32M | 16.14M |
| SG&A | 279.17M | 299.84M | 352.74M | 255.21M | 233.17M | 150.12M | 95.84M | 58.32M | 47.96M | 31.49M | 21.91M | 33.20M |
| Other Expenses | 133.30M | 119.01M | 11.73M | 18.10M | 18.76M | -150.40K | -185.57K | -587.41K | 22.12M | 664.44K | 586.44K | 0.00 |
| Operating Expenses | 569.91M | 581.19M | 469.31M | 345.92M | 309.68M | 201.14M | 135.24M | 86.37M | 83.40M | 56.31M | 41.90M | 33.52M |
| Cost & Expenses | 902.55M | 869.27M | 722.90M | 602.85M | 571.54M | 381.15M | 219.31M | 134.63M | 138.68M | 91.26M | 72.37M | 61.06M |
| Interest Income | 14.46M | 16.86M | 10.76M | 6.27M | 6.21M | 5.40M | 5.50M | 4.53M | 3.36M | 172.56K | 200.96K | 165.24K |
| Interest Expense | 364.86K | 16.21M | 256.55K | 141.60K | 4.89M | 1.73M | 8.39M | 4.35M | 95.22K | 67.73K | 46.18K | 0.00 |
| Depreciation & Amortization | 34.66M | 30.03M | 18.31M | 14.95M | 11.80M | 7.42M | 6.51M | 6.00M | 4.86M | 4.06M | 3.95M | 3.08M |
| EBITDA | 340.65M | 366.96M | 360.99M | 349.78M | 295.58M | 124.20M | 87.52M | 79.30M | 44.39M | 48.02M | 42.07M | 39.23M |
| EBITDA Ratio | 28.19% | 31.88% | 38.87% | 37.90% | 36.29% | 25.83% | 31.20% | 40.44% | 24.74% | 35.88% | 38.88% | 39.99% |
| Operating Income | 305.98M | 328.91M | 367.59M | 330.10M | 298.58M | 121.18M | 87.19M | 78.09M | 39.03M | 44.21M | 39.03M | 36.15M |
| Operating Income Ratio | 25.32% | 27.37% | 33.17% | 35.20% | 34.91% | 24.34% | 29.03% | 37.56% | 22.00% | 32.86% | 35.31% | 36.85% |
| Total Other Income/Expenses | -69.60K | 7.97M | -212.93K | -248.95K | -25.58M | 2.67M | -185.57K | 449.99K | 4.47M | 664.45K | -912.52K | 1.05M |
| Income Before Tax | 305.91M | 336.88M | 367.38M | 329.85M | 273.00M | 119.45M | 78.80M | 73.74M | 43.49M | 42.91M | 38.12M | 37.20M |
| Income Before Tax Ratio | 25.31% | 28.04% | 33.15% | 35.18% | 31.92% | 23.99% | 26.24% | 35.47% | 24.52% | 31.90% | 34.48% | 37.93% |
| Income Tax Expense | 28.09M | 29.16M | 45.02M | 46.47M | 36.24M | 13.80M | 10.51M | 10.30M | 5.63M | 5.88M | 5.45M | 5.26M |
| Net Income | 277.82M | 307.72M | 322.36M | 283.37M | 236.76M | 105.65M | 68.28M | 63.44M | 37.87M | 37.03M | 32.67M | 31.94M |
| Net Income Ratio | 22.99% | 25.61% | 29.09% | 30.22% | 27.68% | 21.22% | 22.74% | 30.51% | 21.35% | 27.53% | 29.55% | 32.56% |
| EPS | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 | 0.20 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| EPS Diluted | 0.72 | 0.80 | 0.93 | 0.82 | 0.68 | 0.31 | 0.20 | 0.18 | 0.12 | 0.15 | 0.13 | 0.13 |
| Weighted Avg Shares Out | 385.87M | 383.57M | 346.62M | 345.58M | 345.85M | 345.85M | 344.87M | 344.79M | 345.85M | 250.00M | 250.00M | 250.00M |
| Weighted Avg Shares Out (Dil) | 385.87M | 384.65M | 346.62M | 345.58M | 348.18M | 345.85M | 345.85M | 345.85M | 345.85M | 250.00M | 250.00M | 250.00M |
Source: https://incomestatements.info
Category: Stock Reports